Syra Health, Corp. (SYRA) Value Adjusted for Debt and Cash

Syra Health Corp. (SYRA) provides specialized mental health analysis software to US government agencies, shielding itself from price wars through stringent security standards. This price chart illustrates an Enterprise Value of , while the company's cloud IT infrastructure scales seamlessly to accommodate new orders. Financial stability is underpinned by multi-year government agreements and the provision of qualified medical personnel.

SYRA Syra Health Corporation: Enterprise Value in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Syra Health Corp.

- price and consensus price forecast:
Market Price Syra Health Corp|SYRA - Price Target Chart
- market capitalization data:
Market Value Syra Health|SYRA - Enterprise Value
- book capitalization data:
Book Value per Share Syra Health|SYRA - Book Capitalization|Market Capitalization to Book Value syrahealth.com|SYRA - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital Syra Health Corp.|SYRA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital syrahealth.com|SYRA - Company Debts|Debt to Book Value Syra Health|SYRA - Company Long-Term Debts|Short-Term Debt Syra Health
Fundamental company valuation:SYRA (Syra Health Corp)

To objectively measure the operational success of Syra Health Corp. (SYRA), investors must evaluate not only the market capitalization but also the company's total liabilities when acquiring its analytical platforms. The enterprise value trend combines the market price of shares and net debt, allowing for the determination of the real value of this predictive medicine technology business for long-term investment planning.

Direct competitors

Veeva Systems - Total Enterprise Value|Total Company Value Doximity Corp (DOCS)|HQY - Value Adjusted for Debt and Cash|WAY: Enterprise Value|corvel.com (CRVL) - Enterprise Value|PRVA: Enterprise Value|Company Buyout Price Huron Consulting Group Inc. (HURN)|Real Price to Acquire Entire Company Certara Corp|Aggregate Business Value Omnicell Health OMCL|Real Price to Acquire Entire Company GoodRx Holdings, Inc.|schrodinger.com - Value Adjusted for Debt and Cash|PHR: Total Company Value|OMDA - Real Price to Acquire Entire Company|Enterprise Value EVH|HealthStream Learning (HSTM) - Total Enterprise Value|Enterprise Value Definitive Healthcare (DH)|Business Value CCSI|AGL (agilon health) - Total Company Value|Company Buyout Price Absci Corp ABSI|SY: Real Price to Acquire Entire Company|NRC Health - Total Enterprise Value|Total Company Value Spok Holdings, Inc. (SPOK)|OPRX - Value Adjusted for Debt and Cash|TBRG: Enterprise Value|Enterprise Value Simulations Plus Inc|SOPH - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Health Catalyst Inc|CareCloud, Inc. (CCLD) - Enterprise Value|Value Adjusted for Debt and Cash Research Solutions Inc. (RSSS)|DLHC: Enterprise Value|Total Enterprise Value OneMedNet Corp ONMD|Scienture Holdings Inc. - Enterprise Value|HCTI: Enterprise Value|ispecimen.com (ISPC) - Total Company Value|Total Company Value Bullfrog AI|SCWorx (WORX) - Real Price to Acquire Entire Company|Aggregate Business Value MSP Recovery Inc.|iCoreConnect Inc. (ICCT) - Enterprise Value|Value Adjusted for Debt and Cash TRxADE Health Corp MEDS|Real Price to Acquire Entire Company Orgenesis Inc.|Value Adjusted for Debt and Cash R1 RCM, Inc. RCM|SHCR: Enterprise Value|STRM: Real Price to Acquire Entire Company|Total Company Value AMEH|MODN (Model N Corporation) - Total Enterprise Value|NXGN - Total Company Value